{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:23:14Z","timestamp":1768450994080,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010886","name":"Weifang Medical University","doi-asserted-by":"publisher","award":["02193701"],"award-info":[{"award-number":["02193701"]}],"id":[{"id":"10.13039\/501100010886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bbrc.2021.08.057","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T10:48:16Z","timestamp":1630925296000},"page":"7-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["UBE2S exerts oncogenic activities in urinary bladder cancer by ubiquitinating TSC1"],"prefix":"10.1016","volume":"578","author":[{"given":"Hao","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le-Le","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2145-6333","authenticated-orcid":false,"given":"Jin-Sheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2021.08.057_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2021.08.057_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1017\/S0033583510000259","article-title":"Structure, function and mechanism of the anaphase promoting complex (APC\/C)","volume":"44","author":"Barford","year":"2011","journal-title":"Q.\u00a0Rev. Biophys."},{"key":"10.1016\/j.bbrc.2021.08.057_bib3","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1186\/s12885-015-1786-8","article-title":"E2-EPF UCP regulates stability and functions of missense mutant pVHL via ubiquitin mediated proteolysis","volume":"15","author":"Park","year":"2015","journal-title":"BMC Canc."},{"key":"10.1016\/j.bbrc.2021.08.057_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.gde.2010.10.004","article-title":"Ubiquitin networks in cancer","volume":"21","author":"Kirkin","year":"2011","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbrc.2021.08.057_bib5","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/ncb1983","article-title":"UBE2S elongates ubiquitin chains on APC\/C substrates to promote mitotic exit","volume":"11","author":"Garnett","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2021.08.057_bib6","doi-asserted-by":"crossref","first-page":"9767","DOI":"10.2147\/OTT.S228522","article-title":"Oncogenic activities of UBE2S mediated by VHL\/HIF-1\u03b1\/STAT3 signal via the ubiquitin-proteasome system in PDAC","volume":"12","author":"Wang","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.bbrc.2021.08.057_bib7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.7150\/ijms.40243","article-title":"Ube2S regulates Wnt\/\u03b2-catenin signaling and promotes the progression of non-small cell lung cancer","volume":"17","author":"Qin","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bbrc.2021.08.057_bib8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.bbrc.2018.06.093","article-title":"UBE2S enhances the ubiquitination of p53 and exerts oncogenic activities in hepatocellular carcinoma","volume":"503","author":"Pan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2021.08.057_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biocel.2019.01.014","article-title":"UBE2S mediates tumor progression via SOX6\/\u03b2-Catenin signaling in endometrial cancer","volume":"109","author":"Lin","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbrc.2021.08.057_bib10","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jid.2020.05.113","article-title":"Comprehensive investigation into the role of ubiquitin-conjugating enzyme E2S in melanoma development","volume":"141","author":"Wang","year":"2021","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.bbrc.2021.08.057_bib11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/onc.2017.349","article-title":"TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex","volume":"37","author":"Guo","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2021.08.057_bib12","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/labinvest.2010.133","article-title":"Expanding therapeutic targets in bladder cancer: the PI3K\/Akt\/mTOR pathway","volume":"90","author":"Ching","year":"2010","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2021.08.057_bib13","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1073\/pnas.0912802107","article-title":"UBE2S drives elongation of K11-linked ubiquitin chains by the anaphase-promoting complex","volume":"107","author":"Wu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2021.08.057_bib14","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1096\/fj.15-274522","article-title":"Appropriate expression of Ube2C and Ube2S controls the progression of the first meiotic division","volume":"29","author":"Ben-Eliezer","year":"2015","journal-title":"Faseb. J."},{"key":"10.1016\/j.bbrc.2021.08.057_bib15","doi-asserted-by":"crossref","first-page":"18213","DOI":"10.1073\/pnas.0907887106","article-title":"Identification of a physiological E2 module for the human anaphase-promoting complex","volume":"106","author":"Williamson","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2021.08.057_bib16","volume":"13","author":"Liess","year":"2020"},{"key":"10.1016\/j.bbrc.2021.08.057_bib17","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.bbrc.2017.02.138","article-title":"UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system","volume":"485","author":"Yoshimura","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2021.08.057_bib18","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.2353\/ajpath.2010.090872","article-title":"Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma","volume":"176","author":"Hansel","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2021.08.057_bib19","first-page":"425","article-title":"Neuromuscular abundance of RB1CC1 contributes to the non-proliferating enlarged cell phenotype through both RB1 maintenance and TSC1 degradation","volume":"18","author":"Chano","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbrc.2021.08.057_bib20","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.cellsig.2008.01.020","article-title":"Pam (Protein associated with Myc) functions as an E3 ubiquitin ligase and regulates TSC\/mTOR signaling","volume":"20","author":"Han","year":"2008","journal-title":"Cell. Signal."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21012407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21012407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:10:14Z","timestamp":1757765414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21012407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":20,"alternative-id":["S0006291X21012407"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.08.057","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UBE2S exerts oncogenic activities in urinary bladder cancer by ubiquitinating TSC1","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.08.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}